Tumor Effect Equipment
-
Manufactured by Hebei Lingding Biotechnology Co., Ltd.based in CHINA
, including a broad spectrum of antibacterial, antiviral and anti-tumor effects, and is related to many important physiological processes in the body, such as regulating the balance of iron in the body, regulating the generation of bone marrow cells, promoting cell growth, regulating the body's immune function, enhancing the body's resistance to ...
-
Manufactured by Ascelia Pharma ABbased in SWEDEN
Oncoral is a novel daily irinotecan chemotherapy in development. Irinotecan chemotherapy has an established potent anti-tumor effect – even in difficult to treat cancers. Oncoral is a daily irinotecan tablet with the potential to offer better patient outcomes with improved safety following the daily dosing at home compared to ...
-
Manufactured by Affimed GmbHbased in GERMANY
AFM24, an EGFR-directed ICE® (innate cell engager) molecule, represents a distinctive mechanism that engages innate immune cells by recruiting NK cells and macrophages to the site of the tumor for effective and efficient tumor-cell killing. Potential to treat various solid tumor types with a more acceptable safety profile ...
-
Manufactured by Alpinion Medical Systems Co., Ltd.based in SOUTH KOREA
, ablation for solid tumor, mechanical and cavitation effect in ex-vivo / in-vivo study. Optimally designed for research laboratories, the VIFU 2000 is a compact and integrated system to offer efficient space management, providing accurate treatment results and improving research ...
-
Manufactured by Vedanta Biosciences, Incbased in USA
VE800 is an orally administered rationally-defined bacterial consortium immuno-oncology candidate. VE800 consists of 11 clonal human commensal bacteria strains manufactured under cGMP conditions and selected for their ability to induce CD8+ T cells, potentiate the immune system’s attack of tumors and enhance the effects of ...
-
Manufactured by CytomX Therapeutics, Inc.based in USA
Probody therapeutics are designed to outsmart cancer by exploiting the unique conditions of the tumor microenvironment to more effectively localize treatment to the tumor, while limiting activity in healthy tissues. These novel therapies are designed to take advantage of high levels of protease activity in the tumor ...
-
Manufactured by MabGenesis Inc.based in JAPAN
Technology and knowledge on variable region amplification and optimal combinations of heavy and light chains: A high-quality library (MOURA library) consisting of 1011 diverse and functional clones, constructed by original gene amplification technology. Covering almost all antibody repertoires of individuals: Covers a wide repertoire of antibodies, including autoantibodies, using pre-B cells from ...
-
Manufactured by Oxford Vacmedix UK Limitedbased in UNITED KINGDOM
Tumours can often avoid being targeted by these T Cells by looking like a cell found normally in the body often referred to as “self”. If a group of T Cells can be encouraged to recognise these tumours as foreign and not self then they will attack the tumour and provide an effective treatment against it. Injecting a ...
-
by IBAbased in BELGIUM
Proteus® has been inspired by everyday clinical practice. Through day-to-day interactions with the community, IBA is perfectly positioned to understand, and invest in, the user’s needs. These investments are directly translated into benefits for the patients. The Proteus® design enhances the patient experience by fostering a soothing environment while making the medical ...
-
Manufactured by Kymab, a Sanofi companybased in UNITED KINGDOM
Alomfilimab SAR445256 (formerly KY1044) is a human monoclonal IgG1 that selectively binds to Inducible T cell CO-stimulator (ICOS), a protein expressed at high levels on immunosuppressive regulatory T cells and at lower levels on effector T cells. Alomfilimab is designed to exert anti-tumour activity through preferential depletion of ...
-
Manufactured by Eutilex Co.,Ltd.based in SOUTH KOREA
4-1BB mAb-based, tumor antigen targeting bispecific ...
-
Manufactured by Dilon Technologies Inc.based in USA
The Dilon Navigator provides the best gamma probe value in the market. The Dilon Navigator 2.0 combines the reliability and features of its predecessor, the Navigator GPS, with state-of-the-art wireless probe technology in a new, sleek design. Lightweight and compact, this system is the ultimate in portability and the advanced battery technology allows for optimal placement of the control unit in ...
-
based in USA
CD123 is expressed on multiple malignancies including BPDCN, AML, certain myeloproliferative neoplasms (MPNs), myelodysplastic syndrome (MDS), chronic myeloid leukemia (CML), B-cell acute lymphoid leukemia (B-ALL), hairy cell leukemia, and Hodgkin’s and certain non-Hodgkin’s lymphomas. In addition to expression on tumor bulk, ...
-
Manufactured by Scancellbased in UNITED KINGDOM
ImmunoBody vaccines are designed to generate potent T cell responses capable of a broad anti-tumour effect. They are DNA vaccines that encode a protein in the form of an antibody, but the parts of the antibody that would normally bind to the target protein are replaced with epitopes from a cancer ...
-
Manufactured by POP Biotechnologies, Inc. (POP BIO)based in USA
PhotoDOX is a revolutionary cancer therapy designed to address solid tumors which are resistant to current standards of care through the innovative benefits of the light-activated PoP-liposome drug delivery ...
-
based in USA
Our plasmid DNA delivery platform is designed to boost the body’s immune system to target and attack ...
-
Manufactured by Datar Cancer Geneticsbased in UNITED KINGDOM
Exacta™ is an intensive and in-depth multi-analyte tumor profiling. It analyses millions of data points at the molecular and functional levels to reveal threats and vulnerabilities which enable optimal identification of targets for precision treatment ...
-
based in DENMARK
PIONEER is our proprietary AI platform for the rapid discovery and design of patient-specific neoepitopes used to derive immuno-oncology therapies. It has been shown that neoepitopes, which arise from patient-specific tumor mutations, play a critical role in T-cell mediated antitumor immune ...
-
Manufactured by IN8Bio Inc.based in USA
Our DeltEx platform has enabled a deep pipeline of preclinical and clinical product candidates, which are designed to effectively target and potentially eradicate disease, to improve patient ...
-
Manufactured by CyberKnife, by Accuray Incorporatedbased in USA
The CyberKnife System is a non-invasive treatment for cancerous and non-cancerous tumors and other conditions where radiation therapy is indicated. It is used to treat conditions throughout the body, including the prostate, lung, brain, spine, head and neck, liver, pancreas and kidney, and can be an alternative to surgery or for patients who ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you